Famione Expert Advisor and Embryologist Yutaro Kawaguchi Presents Research at the Asia-Pacific Initiative on Reproduction (ASPIRE 2026)

Key facts

  • Famione Expert Advisor and Embryologist Yutaro Kawaguchi Presents Research at the Asia-Pacific Initiative on Reproduction (ASPIRE 2026)
  • Yutaro Kawaguchi, an expert advisor and embryologist at Famione, presented two research studies at the 15th ASPIRE 2026 conference held in Beijing from May 7–10, 2026. The research focused on improving fertilization rates using frozen-thawed oocytes and the impact of BMI on semen analysis results.
  • Source: PR Times
  • Date: May 30, 2026

Direct answer

Yutaro Kawaguchi, an expert advisor and embryologist at Famione, presented two research studies at the 15th ASPIRE 2026 conference held in Beijing from May 7–10, 2026. The research focused on improving fertilization rates using frozen-thawed oocytes and the impact of BMI on semen analysis results.

Citation
Famione Expert Advisor and Embryologist Yutaro Kawaguchi Presents Research at the Asia-Pacific Initiative on Reproduction (ASPIRE 2026) (May 30, 2026), PR Times
Source
PR Times
Date
May 30, 2026
Yutaro Kawaguchi, an expert advisor and embryologist at Famione, presented two research studies at the 15th ASPIRE 2026 conference held in Beijing from May 7–10, 2026. The research focused on improving fertilization rates using frozen-thawed oocytes and the impact of BMI on semen analysis results.
イベントNQ 84/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 30, 2026 at 20:00
  • 🔍 Collected: May 30, 2026 at 11:32
  • 🤖 AI Analyzed: May 30, 2026 at 11:34 (1 min after Collected)
Yutaro Kawaguchi, an expert advisor and embryologist at Famione (HQ: Shibuya, Tokyo; CEO: Yusuke Ishikawa)—a healthcare support service provider helping corporate employees and municipal residents—attended the 15th Asia Pacific Initiative on Reproduction (ASPIRE 2026) conference in Beijing, China, from May 7–10, 2026, where he presented two research studies.

About ASPIRE
Founded in 2001, the Asia Pacific Initiative on Reproduction (ASPIRE) aims to improve knowledge and awareness of ART and fertility-related services, ultimately enhancing the quality of patient care.

Overview of ASPIRE 2026 Beijing
Held under the theme "Traveling the Silk Road of Reproductive Medicine," the conference in Beijing attracted over 3,000 professionals, including physicians, nurses, embryologists, and researchers from across the globe.

Research Presentations
Famione's expert advisor, Yutaro Kawaguchi, presented two posters, with CEO Yusuke Ishikawa and Lead Nurse Nishioka participating as co-authors:

Research 1: CONFIRMING SPINDLE FORMATION IN OOCYTES BEFORE CRYOPRESERVATION CAN IMPROVE FERTILIZATION RATES DURING ICSI USING THAWED FROZEN OOCYTES.
Research 2: SEMEN ANALYSIS RESULTS ARE INFLUENCED BY THE PATIENT'S BMI, WHICH AFFECTS THE OUTCOMES OF IN VITRO FERTILIZATION.

Overview of Famione
Famione supports corporate health management and the empowerment of women through expert seminars and individual online consultations. Since its launch in 2018, it has been widely adopted by private companies and municipalities across Japan, establishing a top-tier track record in areas such as pre-conception care.

FAQ

Where was ASPIRE 2026 held?

It was held at The China International Convention Center (CNCC) in Beijing, China from May 7 to 10, 2026.

Who from Famione participated in the presentation?

Yutaro Kawaguchi, a specialized advisor and embryologist, presented, with Yosuke Ishikawa, the representative, and Nishioka, the chief nurse, as co-authors.

What research did Yutaro Kawaguchi present?

He presented two studies: one on improving fertilization rates in ICSI using frozen-thawed oocytes, and another on the impact of patient BMI on semen analysis results.

What is the overview of Famione Inc.'s services?

Famione Inc. provides healthcare support services for employee benefits and resident support, offering online consultations with nurses and psychologists, and expert seminars.

What is ASPIRE?

ASPIRE is a reproductive medicine society established in 2001 to enhance knowledge and improve patient care quality in ART (Assisted Reproductive Technology) and infertility-related services in the Asia-Pacific region.